Mineralys Therapeutics, Inc. MLYS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.23B.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s market capitalization?
- Mineralys Therapeutics, Inc. (MLYS) reported market capitalization of $2.23B in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s market capitalization changed year-over-year?
- Mineralys Therapeutics, Inc.'s market capitalization increased by 123.8% year-over-year, from $997.24M to $2.23B.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s market capitalization?
- Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s market capitalization has grown at a 188.6% compound annual growth rate (CAGR), from $344.8M to $2.87B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.